Does CABOZANTINIB Cause Dermatitis bullous? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Dermatitis bullous have been filed in association with CABOZANTINIB. This represents 0.1% of all adverse event reports for CABOZANTINIB.
5
Reports of Dermatitis bullous with CABOZANTINIB
0.1%
of all CABOZANTINIB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Dermatitis bullous From CABOZANTINIB?
Of the 5 reports, 1 (20.0%) resulted in death, 2 (40.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Dermatitis bullous Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB Cause?
Diarrhoea (404)
Fatigue (263)
Malignant neoplasm progression (238)
Nausea (215)
Decreased appetite (191)
Off label use (190)
Hypertension (165)
Pyrexia (162)
Vomiting (157)
Asthenia (153)
What Other Drugs Cause Dermatitis bullous?
LINAGLIPTIN (275)
ACETAMINOPHEN (157)
IBUPROFEN (142)
FUROSEMIDE (140)
PEMBROLIZUMAB (136)
METHOTREXATE (129)
VANCOMYCIN (115)
CARBOPLATIN (105)
ESOMEPRAZOLE (103)
NIVOLUMAB (103)
Which CABOZANTINIB Alternatives Have Lower Dermatitis bullous Risk?
CABOZANTINIB vs CABOZANTINIB S-MALATE
CABOZANTINIB vs CAFFEINE
CABOZANTINIB vs CALASPARGASE PEGOL
CABOZANTINIB vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB vs CALCIFEDIOL